latest news on glp 1 Some podiatrists are voicing concerns about a new GLP-1 side effect known as "Ozempic feet." More information the condition is available here: https://fox59.com/news/national-world/ozempic-feet-the-latest -side-effect-among-glp-1-users-doctors-warn/ Lipsitz, Ponterio & Comerford |

Entre os efeitos indesejados mais comuns, esto distrbios gastrointestinais como nuseas, vmitos, diarreia ou at dores abdominais, frequentemente observados no incio do tratamento

Glucagon-like peptide-1 Receptor agonists (GLP-1Ras) such as liraglutide and semaglutide have been recently approved as medications for chronic weight management in people living with obesity (PwO)

Board-certified physicians prescribe and manage GLP-1 medications including Wegovy, Saxenda, Zepbound, and Qsymia as part of a comprehensive, medically supervised weight loss plan.

Background Inflammation is a common pathological phenomenon of osteoarthritis (OA)

Foods rich in fiber, protein and healthy fats are associated with better secretion of GLP-1 levels in the body

With new approvals for cardiovascular risk reduction and OSA, GLP1s are reshaping treatment paradigms across comorbid conditions and gaining traction with a broader set of providers